Thanks for submitting the form. A member from PointCross Life Sciences will get in touch with you shortly regarding your request for a demo.
Check out some of our latest blog posts:
September 2024
Hexaware Launches Clinical Data Automation as a Solution (CDAaaS) in Partnership with PointCross Life Sciences
Hexaware Technologies, a global provider of IT services and solutions serving X of top 20 leading pharmaceutical sponsor companies, and PointCross Life Sciences, today announced a partnership to introduce Clinical Data Automation as a Solution (CDAaaS) powered by PointCross’ Xbiom™ platform. This solution is designed to enhance the clinical data lifecycle, from collection to...
Unlocking Insights: Cross-Study Analysis of SEND Datasets with Xbiom™
For those who couldn't join us live, we're excited to share the recording of our third SEND webinar! This session focused on Cross-Study Analysis of SEND Datasets using Xbiom™, where we covered everything from building a solid study repository to comparing datasets from similar compounds and classes. During this webinar session, you will learn: Why you...
August 2024
Webinar on Visualization of SEND datasets
Date: Wednesday, July 31st, 2024Time: 09:00 AM PT / 12:00 PM ET PointCross Life Sciences held a webinar on Visualizing your SEND datasets. What we covered: How to visualize SEND datasets for QC Conducting in-depth subject-level reviews Mastering cross-study comparison and analysis Understanding the limitations of using only SEND datasets for visualizations Exploring pre-templated and customized TFLs This session is tailored for...
June 2024
Clinical Research Metadata Management: The Role of Xbiom by PointCross
Table of ContentsThe Importance of Metadata Management in Clinical Research Xbiom: A Comprehensive Solution Centralized Metadata Repository Scalability and Flexibility Enhanced Data Integration Regulatory Compliance User-Friendly Interface Advanced Analytics and Reporting Security and Access Control Xbiom Functional Components: Enhancing Metadata Management 1. Metadata Repository 2. Centralized Data Repository 3. Regulatory Workflow In the fast-paced world of clinical research, having a flexible and reliable system for managing metadata...
May 2024
Webinar on The Most Common Issues in Preparing SEND: Explained
In this webinar, we discussed how SEND-ASSURE ensures consistency with the audited Study Report, conformance to Technical Rejection Criteria guidelines, and follows details of the Technical Conformance Guide as the trusted references for data submission and regulatory compliance. Key Takeaways: The most common errors in SEND with recommendations to correct them Feedback related to submission and analysis Pinpoint QC ideas Submit...
PointCross attends Verisian first community event in Hyderabad
We're thrilled to share that our team members, Raja and Arpitha, recently had the privilege to attend Verisian's first community event in Hyderabad. During the event, we had the opportunity to present on: "Leveraging LLMs for Traceable Metadata Specifications and Executable Search Expressions in TFL & ADaM Generation." For those who couldn't make it, fret not!...
March 2024
SOT ToxExpo 2024
PointCross was present at the 2024 SOT #ToxExpo. Date: March 10–14, 2024 Salt Palace Convention Center in downtown Salt Lake City, Utah Takeaways: CROs and Sponsors love PointCross’ instant SEND quote generator, fast turnaround time, and study data visualization offering Integrating bioanalytical and complex biomarker data with as collected in-life data can be done in real time and people loved seeing subject level study details for ongoing...
February 2024
Interim Nonclinical Study Monitoring with Xbiom™ Insights
In nonclinical studies, waiting until the completion of a study to make data-driven decisions may limit the potential for valuable insights. Traditional study reports published post-completion often lack the ability to provide on-study analysis and early indicators crucial for driving amendments and gaining deeper insights. Here comes Xbiom™ Insights, a cutting-edge interim nonclinical study...